Forms | FDA - U.S. Food and Drug Administration
Depending on the browser you are using, you may need to download the form to enable field fillable functionality. Use the following instructions to download the form if you encounter an issue...
instructions for filling out form fda 356h – application to market a new or abbreviated new drug or biologic for human use
Abbreviated New Drug Application (ANDA) Forms and Submission ...
Oct 13, 2023 · Form FDA-356h: Application to Market a New Drug, Biologic, or Antibiotic Drug for Human Use (PDF - 2 MB) Instructions for using Form FDA-356h (PDF - 129 KB)
- [PDF]
FORM FDA 356h
FORM FDA 356h Author: PSC Publishing Services Subject: Application to Market a New or Abbreviated New Drug or Biologic for Human Use Created Date: 4/10/2018 2:03:59 PM
Required Forms - Food and Drug Administration
To apply to market a new drug, biologic, or an antibiotic drug for human use, you need to complete Form 356h. Form 356h includes information such as applicant information, proposed indication,...
FDA Form 356h | The Basics You Need to Know
Jan 6, 2025 · FDA Form 356h, officially titled "Application to Market a New or Abbreviated New Drug or Biologic for Human Use", serves as a cover sheet for your regulatory submission. It provides the FDA with a snapshot of your application, including applicant details, submission type, and supporting documents.
- [PDF]
FDA 356h
FDA 356h Author: PSC Publishing Services Subject: Application to Market a New or Abbreviated New Drug or Biologic for Human Use\r\n\(Title 21, Code of Federal Regulations, Part 314 & 601\) Created Date: 7/2/2012 10:29:45 AM
Manufacture. For these products, FDA is now implementing the BLA (revised Form FDA 356h) and will accept biologics license applications instead of two separate license
FORM FDA 356h Author: PSC Publishing Services Subject: Application to Market a New or Abbreviated New Drug or Biologic for Human Use Created Date: 4/10/2018 2:03:59 PM
Facilities and the 356h Form - Ensuring All Relevant ... - Parexel
May 22, 2023 · Internally at the FDA this GFI is commonly referred to as the ‘356h guidance’, as it covers the information required on the FDA 356h form when submitting original or supplemental new drug application, abbreviated new drug application, biologics license application or …